Brain's Painkilling Process

When a natural painkiller is stimulated too frquently, then the responding brain cell receptors close down, making it ineffective, states a new study. br>
The study has important implications for drug development.

The natural painkiller, 2-AG, is one of the two major "endocannabinoid" neurotransmitters.

Experts Set New Guideline for Prescribing Opioid Pain Drugs
A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based

The other, anandamide, can be kept at high levels in the brain without losing its therapeutic effects, and researchers had hoped that the same would be true for 2-AG.

"One implication is that maximally elevating 2-AG levels in the brain might not provide a straightforward path to new pain drugs," Nature quoted Dr. Benjamin F. Cravatt III as saying.

"But we remain optimistic that more modest elevations in 2-AG could produce sustained pain relief. Perhaps more importantly, on a basic science level, we've been able to tease apart a key difference between the two major endocannabinoid signaling pathways, since one can maximally elevate anandamide without observing tolerance," he added.

Cancer Pain - Causes - Effects - Assessment - Treatment - FAQs - Video
Every 1 out of 3 people undergoing cancer treatment experiences pain.

Like the opioid system, the endocannabinoid system was discovered as a result of humans identifying a plant - in this case marijuana (cannabis sativa) - that artificially boosts its activity. Marijuana's main active ingredient, THC, typically reduces pain and anxiety.

Researchers have sought to develop drugs that reproduce such therapeutic effects while leaving out THC's unwanted side effects - which include memory impairment, locomotor dysfunction, and possibly addiction.

European Regulators Investigate Common Painkiller Drugs
European regulators are investigating common painkiller drugs after researchers warned that some of them might increase the risk of heart attack.

Cannabinoid research received a boost in 1990 with the description of the main cannabinoid receptor in the brain, CB1, and a few years later with the discoveries of the body's own (endo-) cannabinoids, anandamide and 2-AG, which exert most of their effects by binding to CB1.

Researchers have said that 2-AG's pain-killing effect disappears after six days of treatment.

Lifelong Addiction is Possible in Adolescents Due to Painkiller Abuse
Brains of children may undergo changes where the reward system is not satisfied until it receives a fix.

"When you continually stimulate the endocannabinoid system by maximally raising 2-AG levels, you effectively desensitize the system," said Cravatt.

The report appears in the latest issue of Nature Neuroscience.

Source-ANI

Brain's Painkilling Process - New Facts